Ariane Dunant
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Breast Cancer Treatment Studies, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Drug-Induced Adverse Reactions
Most-Cited Works
- → Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group(2008)2,629 cited
- → DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy(2006)1,723 cited
- → Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study(2007)982 cited
- → ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis(2010)715 cited
- → Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)(2007)555 cited
- → Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel(2007)478 cited
- → Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis(2013)432 cited
- → Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer(2009)392 cited
- → ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer(2013)363 cited
- → Adjuvant chemotherapy for resected early-stage non-small cell lung cancer(2015)363 cited